Water

Water

SCHEMBL7100681

O.OCC1CNCCC1c1ccc(F)cc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 3/20 0.51
SLC6A4 known ✓ P31645 4/20 0.50
SLC6A2 known ✓ P23975 3/20 0.50
HTR2A known ✓ P28223 3/20 0.50
HTR2B known ✓ P41595 3/20 0.50
SLC6A3 known ✓ Q01959 3/20 0.50
SCN5A known ✓ Q14524 2/20 0.50
CACNA1F known ✓ O60840 1/20 0.50
ADRB2 known ✓ P07550 1/20 0.50
CHRM2 known ✓ P08172 1/20 0.50
CHRM4 known ✓ P08173 1/20 0.50
HTR1A known ✓ P08908 1/20 0.50
CHRM5 known ✓ P08912 1/20 0.50
ADORA3 known ✓ P0DMS8 1/20 0.50
CHRM1 known ✓ P11229 1/20 0.50
ADRA2C known ✓ P18825 1/20 0.50
CHRM3 known ✓ P20309 1/20 0.50
TACR1 known ✓ P25103 1/20 0.50
ADRA1A known ✓ P35348 1/20 0.50
OPRM1 known ✓ P35372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL4426451 1.00 GRK2 (0.55) GRK2CYP3A4MEN1KMT2ATP53
Water SCHEMBL7100677 1.00 GRK2 (0.55) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL7035325 0.98 GRK2 (0.56) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL4428153 0.98 GRK2 (0.56) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL1945968 0.98 GRK2 (0.56) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL1096634 0.98 GRK2 (0.56) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL4429628 0.98 GRK2 (0.56) GRK2CYP3A4MEN1KMT2ATP53
Cadaverine Tartrate SCHEMBL8195310 0.87 GRK2 (0.47) GRK2CYP3A4MEN1KMT2ATP53
SCHEMBL27611853 0.86 GRK2 (0.47) GRK2CYP3A4MEN1KMT2ATP53
Tert-Butyl Formate SCHEMBL27970140 0.84 GRK2 (0.47) GRK2CYP3A4MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0969002-B1 L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethyl-piperidine compound and process for preparing the same SUMIKA FINE CHEMICALS CO LTD (JP) 2003-08-27 EP disclosed
US-20020028944-A1 L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound and process for preparing the same SUMIKA FINE CHEMICALS CO., LTD. 2002-03-07 US disclosed
US-6316628-B1 REACTING A TRANS-(.+-.)-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYLPIPERIDINE COMPOUND WITH L-TARTARIC ACID IN METHANOL, OR A MIXED SOLVENT OF METHANOL AND ISOPROPYL ALCOHOL OR ACETONE SUMIKA FINE CHEMICALS CO., LTD. (JP) 2001-11-13 US disclosed
EP-0969002-A1 L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethyl-piperidine compound and process for preparing the same SUMIKA FINE CHEMICALS Co., Ltd. (JP) 2000-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028944-A1 L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound and process for preparing the same TPH1, TPH2, TKT MEN1 3725/4885SLC6A4 17/4885SLC6A2 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.